向日葵（300111）投资者索赔分析

Core Viewpoint - Zhejiang Sunflower (Welfare) Health Technology Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may provide compensation opportunities for affected shareholders [1][2]. Group 1: Investigation Details - The company received a notice of investigation from the CSRC on January 14, 2026, due to alleged violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][2]. - The investigation is identified by the case number: CSRC Investigation No. 01120260003 [1]. Group 2: Shareholder Compensation - According to lawyer Xu Jin, investors who suffer losses due to false statements by the company can file civil compensation lawsuits without prior procedures, as per the new judicial interpretation of securities false statements [3]. - The scope of compensation includes investment loss differences, stamp duty, and commission losses [3]. - Preliminary compensation conditions require investors to have purchased shares before January 14, 2026, and either sold them after January 15, 2026, or still hold them at a loss [3]. Group 3: Required Documentation for Claims - Investors seeking compensation should prepare the following documents: a copy of their ID, a confirmation of their securities account opening information (original stamped by the brokerage), and a transaction record from the first purchase of the stock to the present (also stamped by the brokerage) [3].